0.19
0.19 (0%)
As of May 29, 2025
Bioaffinity Technologies, Inc. [BIAFW]
Source:
Company Overview
Bioaffinity Technologies, Inc. develop proprietary noninvasive diagnostics to detect early-stage lungcancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificialintelligence (“AI”).
Country | United States |
Headquarters | san antonio, texas |
Phone Number | 210-698-5334 |
Industry | |
CEO | Maria Zannes |
Website | bioaffinitytech.com |